`
`Page 1 of 2
`
`FDA Home3 Drug Databases4 Orange Book5
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`Patent and Exclusivity Search Results from query on Appl No 204026 Product 001 in the OB_Rx list.
`
`Patent Data
`
`Appl No
`
`Prod No
`
`Patent No
`
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`N204026
`
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`001
`
`Exclusivity Data
`
`5635517
`5653517
`6045501
`6315720
`6316471
`6476052
`6561976
`6561977
`6755784
`6908432
`8158653
`8198262
`8204763
`8315886
`8589188
`8626531
`8673939
`8735428
`8828427
`
`Patent
`Expiration
`Jul 24, 2016
`Jul 24, 2016
`Aug 28, 2018
`Oct 23, 2020
`Aug 10, 2016
`Jul 24, 2016
`Aug 28, 2018
`Oct 23, 2020
`Oct 23, 2020
`Aug 28, 2018
`Aug 10, 2016
`Oct 19, 2024
`Aug 28, 2018
`Oct 23, 2020
`Aug 28, 2018
`Oct 23, 2020
`May 15, 2023
`May 15, 2023
`Jun 21, 2031
`
`Drug Substance
`Claim
`
`Drug Product
`Claim
`
`Y
`Y
`
`Y
`
`Y
`
`Y
`
`Delist
`Requested
`
`Patent Use
`Code
`U - 1359
`U - 1359
`U - 1361
`U - 1361
`U - 1360
`U - 1360
`U - 1361
`U - 1361
`U - 1361
`U - 1361
`
`U - 1360
`U - 1361
`U - 1361
`U - 1361
`U - 1361
`U - 1360
`U - 1360
`
`Appl No
`
`Prod No
`
`Exclusivity Code
`
`N204026
`N204026
`N204026
`
`001
`001
`001
`
`I - 707
`ODE
`NCE
`
`Exclusivity Expiration
`Apr 23, 2018
`Feb 8, 2020
`Feb 8, 2018
`
`Additional information:
`1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
`2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be
`flagged with respect to other claims which may apply.
`
`View a list of all patent use codes
`View a list of all exclusivity codes
`Return to Electronic Orange Book Home Page6
`
`FDA/Center for Drug Evaluation and Research
`Office of Generic Drugs
`Division of Labeling and Program Support
`Update Frequency:
`Orange Book Data - Monthly
`Generic Drug Product Information & Patent Information - Daily
`Orange Book Data Updated Through June 2015
`Patent and Generic Drug Product Data Last Updated August 05, 2015
`
`Links on this page:
`1. http://www.addthis.com/bookmark.php?u508=true&v=152&username=fdamain
`2. http://www.addthis.com/bookmark.php
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=204026&Pr...
`
`8/6/2015
`
`CFAD VI 1040 - 0001
`CFAD VI v. CELGENE
`IPR2015-01096
`
`
`
`Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations
`
`Page 2 of 2
`
`3. http://www.fda.gov/default.htm
`4. http://www.fda.gov/Drugs/InformationOnDrugs/default.htm
`5.
`../default.cfm
`6.
`../default.cfm
`
`Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
`Accessibility Contact FDA Careers FDA Basics FOIA No Fear Act Site Map Transparency Website Policies
`
`U.S. Food and Drug Administration
`10903 New Hampshire Avenue
`Silver Spring, MD 20993
`Ph. 1-888-INFO-FDA (1-888-463-6332)
`Contact FDA
`
`For Government For Press
`Combination Products Advisory Committees Science & Research Regulatory Information Safety Emergency Preparedness International Programs News &
`Events Training and Continuing Education Inspections/Compliance State & Local Officials Consumers Industry Health Professionals FDA Archive
`
`Links on this page:
`
`http://www.accessdata.fda.gov/scripts/cder/ob/docs/patexclnew.cfm?Appl_No=204026&Pr...
`
`8/6/2015
`
`CFAD VI 1040 - 0002